Contact lens maker Vision Science up for sale The contact lens ODM company exports its products to 30 different countries
Translated by Kim So-in 공개 2019-12-12 08:00:00
이 기사는 2019년 12월 12일 08:39 thebell 에 표출된 기사입니다.
South Korea’s contact lens original development manufacturing (ODM) company Vision Science has been put up for sale. The contact lens manufacturer, which exports its products to 30 different countries around the world, is likely to draw interest from potential buyers.According to industry sources on December 9, Vision Science’s management rights are up for sale. The sell-side hasn’t decided the bidding timeline yet, while the transaction is likely to be a private deal. It is said that several strategic and financial investors have reviewed the buyout of Vision Science. Samil PricewaterhouseCoopers (PwC) is acting as a lead manager of the sale.
Established in 2004, Vision Science has its headquarters in Gyeongsan, North Gyeongsang Province. The company was selected as the promising small and medium enterprise of the region by the Ministry of SMEs and Startups in 2017 and awarded the Innopolis Technology Commercialization Excellent Enterprise last year. Having focused on color contact lenses, the company’s mainstay products are Vision Maxim and Colors Nouveau.
The company received a patent for the Color Lock System, the technology which enables colors of contact lenses to be located between lens layers, in 2016. Vision Science has expanded its distribution routes to China and the U.S., and it clinched 10 million dollars in export in 2014. Its sales recorded 14 billion won last year, which is a 21.8 percent increase compared to 2017. It turned to a 900 million won net profit in the same period.
Domestic contact lens industry has been reshaped by daily disposable lenses. The contact lens market is strictly regulated by each nation’s government agencies. Vision Science received an approval from the U.S. Food and Drug Administration (FDA) in 2014 and China’s National Medical Products Administration (NMPA, formally known as CFDA) has granted priority review status to the company in 2015. These give Vision Science a plenty of room for solid performance.
In this light, market watchers say that strategic investors who are willing to diversify their business and financial investors who got attracted to the company’s upside potential will likely be interested in the management right. “Manufacturers and distributors of consumption goods may review [the acquisition of] Vision Science in order to create synergy. Private equity firms who have portfolio companies that are in the same field may also focus on the company,” said an IB industry source.
(By reporter Rho Arrum)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
best clicks
최신뉴스 in 전체기사
-
- '재무개선' AJ네트웍스, 조달비용 '확' 낮췄다
- '9년만에 엑시트' 한앤코, 한온시스템 거래구조 살펴보니
- 한국타이어앤테크놀로지, 한온시스템 인수한다
- [수술대 오른 커넥트웨이브]2대주주 지분매입 나선 MBK, 주식교환 카드 꺼냈다
- [이사회 모니터]이재용 에이비프로바이오 대표, 바이오·반도체 신사업 '드라이브'
- 와이투솔루션, 주인 바뀌어도 '신약' 중심엔 美 합작사 '룩사'
- 아이티센, 부산디지털자산거래소 본격 출범
- 아이에스시, AI·데이터센터 수주 증가에 '날개'
- [이사회 모니터]서정학 IBK증권 대표, ESG위원회도 참여 '영향력 확대'
- SW클라우드 '10주년' 폴라리스오피스, “초격차 밸류업”